Article
Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma
16 Jul 2025
Abstract excerpt
Multiple myeloma (MM) accounts for 10% of all blood cancers [ 1 ]. Standard of care treatment with autologous stem cell transplantation (ASCT) followed by lenalidomide maintenance improved survival, but MM remains incurable [ 1 ]. A diverse therapeutic armamentarium has changed MM into a relapsing-remitting cancer. However, as patients live several years, there has been a steady increase in the frequency of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
